Filing Details

Accession Number:
0000899243-21-045363
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-19 13:21:19
Reporting Period:
2021-11-18
Accepted Time:
2021-11-19 13:21:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1782223 Pyxis Oncology Inc. PYXS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1723092 Thomas Civik C/O Pyxis Oncology, Inc.
35 Cambridgepark Drive
Cambridge MA 02140
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-18 15,700 $12.74 15,700 No 4 P Indirect By Civik Family Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Civik Family Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.47 to $13.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
  2. These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.